Effects of peroxisome proliferator-activated receptor-gamma agonists on central nervous system inflammation. - Wikidata - wikimedia - TriplyDB

Effects of peroxisome proliferator-activated receptor-gamma agonists on central nervous system inflammation.

Effects of peroxisome proliferator-activated receptor-gamma agonists on central nervous system inflammation.

http://www.wikidata.org/entity/Q35044388

about

Mechanisms and potential therapeutic applications of microglial activation after brain injury Alzheimer Disease: Crosstalk between the Canonical Wnt/Beta-Catenin Pathway and PPARs Alpha and Gamma Glitazones differentially regulate primary astrocyte and glioma cell survival. Involvement of reactive oxygen species and peroxisome proliferator-activated receptor-gamma.PPAR signaling pathway and cancer-related proteins are involved in celiac disease-associated tissue damage.Regulation of oligodendrocyte progenitor cell maturation by PPARδ: effects on bone morphogenetic proteins Cyclopentenone prostaglandins PGA2 and 15-deoxy-delta12,14 PGJ2 suppress activation of murine microglia and astrocytes: implications for multiple sclerosis.9-Cis-retinoic acid suppresses inflammatory responses of microglia and astrocytes.The effects of pioglitazone, a PPARγ receptor agonist, on the abuse liability of oxycodone among nondependent opioid users.Microglia activation and anti-inflammatory regulation in Alzheimer's disease PPARG: Gene Expression Regulation and Next-Generation Sequencing for Unsolved Issues.Effects of peroxisome proliferator-activated receptor alpha/delta agonists on HDL-cholesterol in vervet monkeys.Involvement of PPAR nuclear receptors in tissue injury and wound repair PPARγ agonists promote oligodendrocyte differentiation of neural stem cells by modulating stemness and differentiation genes PPARγ Is Activated during Congenital Cytomegalovirus Infection and Inhibits Neuronogenesis from Human Neural Stem Cells.Endothelial cells and astrocytes: a concerto en duo in ischemic pathophysiology.Protective effect of pioglitazone on morphine-induced neuroinflammation in the rat lumbar spinal cord.Liver X receptor and retinoid X receptor agonists inhibit inflammatory responses of microglia and astrocytes.PPAR-gamma Pro12Ala genotype and risk of cognitive decline in elders Peroxisome proliferator-activated receptor-gamma agonists suppress the production of IL-12 family cytokines by activated glia.Nonsteroidal anti-inflammatory drugs in Parkinson's disease: possible involvement of quinone formation.S. aureus-dependent microglial activation is selectively attenuated by the cyclopentenone prostaglandin 15-deoxy-Delta12,14- prostaglandin J2 (15d-PGJ2)The synthetic peroxisome proliferator-activated receptor-gamma agonist ciglitazone attenuates neuroinflammation and accelerates encapsulation in bacterial brain abscesses.15-deoxy-Delta12,14-prostaglandin J2 (15d-PGJ2) and ciglitazone modulate Staphylococcus aureus-dependent astrocyte activation primarily through a PPAR-gamma-independent pathway.Microglia and Astrocyte Activation by Toll-Like Receptor Ligands: Modulation by PPAR-gamma Agonists The PPAR-gamma Agonist 15-Deoxy-Delta-Prostaglandin J(2) Attenuates Microglial Production of IL-12 Family Cytokines: Potential Relevance to Alzheimer's Disease.RAR/RXR and PPAR/RXR Signaling in Spinal Cord Injury.Retinoic acid-dependent regulation of immune responses by dendritic cells and macrophages.Peroxisome Proliferator-Activated Receptor-gamma in Amyotrophic Lateral Sclerosis and Huntington's Disease.Regulation of Glial Cell Functions by PPAR-gamma Natural and Synthetic Agonists.Peroxisome proliferator-activated receptor-gamma activation suppresses HIV-1 replication in an animal model of encephalitis.Protective Effect of PPARγ Agonists on Cerebellar Tissues Oxidative Damage in Hypothyroid Rats.Novel findings in drug-induced dendritic cell tolerogenicity.Anti-neuroinflammatory agents for the treatment of Alzheimer's disease.The role of neuroinflammation in dementias.PPARγ activation by baicalin suppresses NF-κB-mediated inflammation in aged rat kidney.PPARs in Alzheimer's Disease.Impact and Therapeutic Potential of PPARs in Alzheimer's Disease.Anti-inflammatory and antiproliferative actions of PPAR-gamma agonists on T lymphocytes derived from MS patients.Effects of Wy14643 on hepatic ischemia reperfusion injury in rats.PPARs: a new target for neuroprotection.

P2860

Q26864358-BB68F3A6-411B-4EF0-9A04-3408AEED65AF Q28075617-B3ABFA62-4078-4858-9802-8B83CB7916A0 Q33196298-0741CB2D-3CD4-4DEE-A120-923FD3850EA7 Q33573305-1B0BF134-8582-4384-9A89-08E656FB383F Q33595538-4E26932F-7BE4-4A3A-BA06-BF2C082ACD71 Q33644063-83BBB0F9-8E6A-4D3D-8935-B4EDE0552E2D Q33674869-C84A2BC7-A5A3-4C48-8B7E-40611A5E7728 Q33727021-B5370717-CC8D-4EC0-9E33-3D9EB23984CF Q33943873-D8A41ABC-9C08-4D93-88EC-54D44EF4955A Q34143718-7808A9DC-713D-4734-B27F-F39C01235161 Q34395356-ED21E967-A021-4D67-957B-F3B2BC9D71B4 Q34416422-F2D5FDCE-D63D-4F6C-8BAB-1E47673F3EE0 Q34491511-377F3CF4-43A5-4592-8B1E-093101590602 Q35990083-DF5B6DDF-11DC-4889-8EE0-FB3ADD1151D7 Q36072867-75E2D206-10D2-4927-A972-C566DEB2B0A7 Q36086121-8A0965A1-F1D6-415D-A9AE-6E63718C79CD Q36148455-DD3C1CEA-A4A0-46C1-BA53-42725858FD95 Q36445372-F18D5ECA-94F2-47F4-8441-72E68D0330FF Q36528985-7DF80201-0950-49E4-B8BE-6CE2E91A7DDC Q36607332-31C64A55-E44D-4376-885D-198108A88C20 Q36631061-E01F323B-0CBE-4CAB-9675-AC05E2AE2F9C Q36676619-DCF6D2A5-1E2B-45D8-B4A8-99756633BA6F Q36712237-F52F7DCF-9516-4596-9F46-7EC2E5DEBA14 Q36731548-CD9864E6-D4C6-4043-A444-CD93C8D4DECB Q36742787-0E9CD700-09D8-4DB5-9F1D-811F8BB5C381 Q37024759-BA0A62B6-2EA8-452A-91AF-B54904781D34 Q37096952-1087270F-0836-43BD-859B-A823AE36AE4E Q37157528-51E5B223-EF8E-4E07-8A47-F8E44C85B1BD Q37157531-CE7491FA-70BE-4CBF-8CFC-75DC01481B4F Q37208433-84527B47-F89D-4B20-8ADF-98A74DB7792B Q37571681-A45E853D-19BE-442B-A02C-63A8CABC8E37 Q37809070-755C4B78-20D1-4F6B-A02F-9F31E1D747E7 Q38136313-00220CA4-48E9-40F2-872F-0B06742763F8 Q38365247-7F042D5C-594E-411E-A730-6BB2CCEB5966 Q39451549-43460E5E-E30B-4543-98B6-94605DEC63DD Q40288794-CC9F766C-5E2C-422A-8AB8-3CF68269FEA6 Q40576825-0F8C9546-4F33-40E0-A0C8-B8E8D7C52D3D Q40610269-36218B45-75CB-410E-9BDE-956FBB067659 Q42619953-B8BE6C44-3A6F-41F3-8B1D-E227BACA99D2 Q42718625-A758F628-A3EA-4FB0-B478-3DA004775E66

P2860

Effects of peroxisome proliferator-activated receptor-gamma agonists on central nervous system inflammation.

http://www.wikidata.org/entity/Q35044388

description

2003 nî lūn-bûn

@nan

2003 թուականի Փետրուարին հրատարակուած գիտական յօդուած

@hyw

2003 թվականի փետրվարին հրատարակված գիտական հոդված

@hy

2003年の論文

@ja

2003年論文

@yue

2003年論文

@zh-hant

2003年論文

@zh-hk

2003年論文

@zh-mo

2003年論文

@zh-tw

2003年论文

@wuu

name

Effects of peroxisome prolifer ...... l nervous system inflammation.

@en

type

label

Effects of peroxisome prolifer ...... l nervous system inflammation.

@en

prefLabel

Effects of peroxisome prolifer ...... l nervous system inflammation.

@en

P1433

Q35044388-DAB9EDF7-67C3-42F1-ABCB-EA84D124E178

P1476

Q35044388-907BB7C6-5053-47B2-B8AD-ADA1809700F0

P2093

Q35044388-35BD0C07-CD58-4466-B15F-1877DB74EA76

Q35044388-55F2F046-50F9-454F-8DDD-402B8C9E1D52

P2860

Q35044388-1A481839-5DF0-41E9-BEF2-669EC754EFF4

Q35044388-1F29823E-A94A-4F52-8F33-CD350B7F4FD2

Q35044388-2D2D6D9D-F099-469D-A0EE-B44F92F76E06

Q35044388-30DC903A-2935-49A3-BEF6-A5FA47FC63EB

Q35044388-3C2FFB23-76BA-4334-8C99-F086A7D90491

Q35044388-72B89A4A-33AD-4C35-B49F-4DCED0939D3F

Q35044388-7443C307-C4B0-4914-B459-8CB739472FE9

Q35044388-7725AF6C-2B0A-48A0-B62E-A2EAE0BD162E

Q35044388-784C8C63-91A5-4B9B-BA9F-F87F9A1E7407

Q35044388-BD2A6624-8E91-4DE6-8D4C-65AFE5B265BA

P304

Q35044388-C57AA1C3-5A13-4A61-B559-08E774D19B2F

P31

Q35044388-AFBAB873-4FB8-4E8E-B531-658EC477EDC1

P356

Q35044388-B987BCE8-DE62-4708-B98F-8A4F7EA523DC

P433

Q35044388-FAD29287-BAD8-49E5-A132-2385E30AE3B0

P478

Q35044388-9F2AB9FA-4C73-4E24-A098-1F70183972C3

P577

Q35044388-6AE0C1DA-1C2B-4A7F-86D0-BD9D9FE0E6F2

P698

Q35044388-855705CD-1CF1-4525-88D9-325B19AF543A

P921

Q35044388-36C716BA-C59D-4347-946D-2C7FDD4CB57A

P356

P1433

Journal of Neuroscience Research

P1476

Effects of peroxisome prolifer ...... l nervous system inflammation.

@en

P2093

Paul D Drew

http://www.w3.org/2001/XMLSchema#string

Tammy Kielian

http://www.w3.org/2001/XMLSchema#string

P2860

Peroxisome proliferator-activated receptor-gamma activators inhibit IFN-gamma-induced expression of the T cell-active CXC chemokines IP-10, Mig, and I-TAC in human endothelial cells.

Macrophages in human atheroma contain PPARgamma: differentiation-dependent peroxisomal proliferator-activated receptor gamma(PPARgamma) expression and reduction of MMP-9 activity through PPARgamma activation in mononuclear phagocytes in vitro.

Fos is a preferential target of glucocorticoid receptor inhibition of AP-1 activity in vitro.

Contribution of cyclopentenone prostaglandins to the resolution of inflammation through the potentiation of apoptosis in activated macrophages.

Peroxisome proliferator-activated receptor activators target human endothelial cells to inhibit leukocyte-endothelial cell interaction.

Peroxisome proliferator activator receptor-gamma agonists and 15-deoxy-Delta(12,14)(12,14)-PGJ(2) induce apoptosis in normal and malignant B-lineage cells.

Differential regulation of chemokine gene expression by 15-deoxy-delta 12,14 prostaglandin J2.

15-deoxy-Delta 12,14-PGJ2 induces IL-8 production in human T cells by a mitogen-activated protein kinase pathway.

A proinflammatory role for the cyclopentenone prostaglandins at low micromolar concentrations: oxidative stress-induced extracellular signal-regulated kinase activation without NF-kappa B inhibition.

Prostaglandin D2 and its metabolites induce caspase-dependent granulocyte apoptosis that is mediated via inhibition of I kappa B alpha degradation using a peroxisome proliferator-activated receptor-gamma-independent mechanism.

P304

315-325

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/JNR.10501

http://www.w3.org/2001/XMLSchema#string

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

71

http://www.w3.org/2001/XMLSchema#string

P577

2003-02-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

12526021

http://www.w3.org/2001/XMLSchema#string

P921